Skip to content
10-Q

Quarterly Report

BIOTRICITY INC. BTCY

0001493152-24-046028

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Nov 13, 2024 24.39M sh
Cash And Equivalents Q2 2025 · Sep 30, 2024 $173.27K
Cash And Equivalents Q2 2025 · Mar 31, 2024 $786.06K
Current Liabilities Q2 2025 · Sep 30, 2024 $21.49M
Current Liabilities Q2 2025 · Mar 31, 2024 $22.7M
Total Liabilities Q2 2025 · Sep 30, 2024 $34.17M
Total Liabilities Q2 2025 · Mar 31, 2024 $35.92M
Current Assets Q2 2025 · Sep 30, 2024 $4.06M
Current Assets Q2 2025 · Mar 31, 2024 $4.47M
Total Assets Q2 2025 · Sep 30, 2024 $5.29M
Total Assets Q2 2025 · Mar 31, 2024 $5.94M
Shares Diluted Q2 2025 · Sep 30, 2023 8.8M sh
Shares Diluted Q2 2025 · Sep 30, 2023 8.77M sh
Operating Cash Flow Q2 2025 · Sep 30, 2023 −$4.22M
Stockholders Equity Q2 2025 · Sep 30, 2023 −$26.73M
Stockholders Equity Q2 2025 · Jun 30, 2023 −$23.41M
Stockholders Equity Q2 2025 · Mar 31, 2023 −$19.85M
Eps Diluted Q2 2025 · Sep 30, 2023 −$0.44
Eps Diluted Q2 2025 · Sep 30, 2023 −$0.85
Eps Basic Q2 2025 · Sep 30, 2023 −$0.44
Eps Basic Q2 2025 · Sep 30, 2023 −$0.85
Sga Expense Q2 2025 · Sep 30, 2023 $3.49M
Sga Expense Q2 2025 · Sep 30, 2023 $7.01M
Rd Expense Q2 2025 · Sep 30, 2023 $697.62K
Rd Expense Q2 2025 · Sep 30, 2023 $1.41M
Net Income Q2 2025 · Sep 30, 2023 −$3.69M
Net Income Q2 2025 · Sep 30, 2023 −$7.1M
Operating Income Q2 2025 · Sep 30, 2023 −$2.19M
Operating Income Q2 2025 · Sep 30, 2023 −$4.5M
Gross Profit Q2 2025 · Sep 30, 2023 $2M
Gross Profit Q2 2025 · Sep 30, 2023 $3.92M
Cost Of Revenue Q2 2025 · Sep 30, 2023 $892.02K
Cost Of Revenue Q2 2025 · Sep 30, 2023 $2M
Revenue Q2 2025 · Sep 30, 2023 $2.89M
Revenue Q2 2025 · Sep 30, 2023 $5.91M